| Nevada                                                         |   | 20-3626387                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

----

| Part I - FINANCIAL INFORMATION                                                                      |  2  |
|-----------------------------------------------------------------------------------------------------|----------|
| Item 1. Financial Statements                                                                   |  2  |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |  3  |
| Item 3. Quantitative and Qualitative Disclosures About Market Risk                                  |  9  |
| Item 4. Controls and Procedures                                                                     |  9  |
| PART II - OTHER INFORMATION                                                                         |  10 |
| Item 1. Legal Proceedings                                                                           |  10 |
| Item 1A. Risk Factors                                                                          |  10 |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds                                 |  10 |
| Item 3. Defaults Upon Senior Securities                                                             |  10 |
| Item 4. [Removed and Reserved]                                                                      |  10 |
| Item 5. Other Information                                                                           |  10 |
| Item 6. Exhibits                                                                                    |  11 |

----

Part I – FINANCIAL INFORMATION

Item 1. Financial Statements

|                              | Index |
|-----------------------------------|-------|
| Balance Sheets                    | F-1   |
| Statements of Operations          | F-2   |
| Statements of Cash Flows          | F-3   |
| Notes to the Financial Statements | F-4   |

----

|                                                                                                                                     |   | March 312010$ |       |   | December 31 2009$ |   |
|------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------|------------|--------|------------------------|--------|
|                                                                                                                                     |   | (unaudited)   |       |   |                   |   |
| ASSETS                                                                                                                                   |   |          |       |   |                   |   |
|                                                                                                                                     |   |          |       |   |                   |   |
| Current Assets                                                                                                                           |   |          |       |   |                   |   |
|                                                                                                                                     |   |          |       |   |                   |   |
| Cash                                                                                                                                     |   |          | 47,617     |   |                   |   | 117,489 |   |
| Amounts receivable                                                                                                                       |   |          | 9,810      |   |                   |   | 8,406 |   |
| Investment tax credit receivable (Note 2(n))                                                                                             |   |          | 14,880     |   |                   |   | 14,880 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Total Current Assets                                                                                                                     |   |          | 72,307     |   |                   |   | 140,775 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Property and equipment (Note 3)                                                                                                          |   |          | 10,632     |   |                   |   | 11,374 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Total Assets                                                                                                                             |   |          | 82,939     |   |                   |   | 152,149 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT                                                                                              |   |          |       |   |                   |   |   |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Current Liabilities                                                                                                                      |   |          |       |   |                   |   |   |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Accounts payable                                                                                                                         |   |          | 28,489     |   |                   |   | 48,584 |   |
| Accrued liabilities                                                                                                                      |   |          | 16,349     |   |                   |   | 1,702 |   |
| Accrued convertible interest payable to related parties (Note 5)                                                                         |   |          | 14,806     |   |                   |   | 11,785 |   |
| Advances from related parties (Note 6(a))                                                                                                |   |          | 26,906     |   |                   |   | 26,906 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Total Current Liabilities                                                                                                                |   |          | 86,550     |   |                   |   | 88,977 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Convertible debentures issued to related parties (Note 5)                                                                                |   |          | 250,708    |   |                   |   | 250,951 |   |
| Advances from related parties (Note 6(b))                                                                                                |   |          | 25,395     |   |                   |   | 26,275 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Total Liabilities                                                                                                                        |   |          | 362,653    |   |                   |   | 366,203 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Contingencies and Commitments (Notes 1 and 9)                                                                                            |   |          |       |   |                   |   |   |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Stockholders’ Deficit                                                                                                              |   |          |       |   |                   |   |   |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Common stock, 75,000,000 shares authorized, US$0.001 par value;45,569,068 shares issued and outstanding (2009 – 45,869,068 shares) |   |          | 52,810     |   |                   |   | 53,158 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Additional paid-in capital                                                                                                               |   |          | 1,634,994  |   |                   |   | 1,632,019 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Common stock to be issued (Note 7(b))                                                                                                    |   |          | 2,320      |   |                   |   | 2,627 |   |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Deficit accumulated during the development stage                                                                                         |   |          | (1,969,838 | )      |                   |   | (1,901,858 | ) |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Total Stockholders’ Deficit                                                                                                        |   |          | (279,714   | )      |                   |   | (214,054 | ) |
|                                                                                                                                     |   |          |       |   |                   |   |   |   |
| Total Liabilities and Stockholders’ Deficit                                                                                        |   |          | 82,939     |   |                   |   | 152,149 |   |

----

|                                             |   | Accumulated from    |       |   | For the      |   |       | For the      |   |
|--------------------------------------------------|--------|---------------------|------------|--------|--------------|--------|------------|--------------|--------|
|                                             |   | March 6, 1999       |       |   | Three months |   |       | Three months |   |
|                                             |   | (Date of Inception) |       |   | Ended        |   |       | Ended        |   |
|                                             |   | to March 31,        |       |   | March 31,    |   |       | March 31,    |   |
|                                             |   | 2010$               |       |   | 2010$        |   |       | 2009$        |   |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Revenue                                          |   |                | –    |   |         |   | –    |         |   |   | – |   |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Expenses                                         |   |                |       |   |         |   |       |         |   |   |   |   |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Depreciation                                     |   |                | 15,735     |   |         |   | 742        |         |   |   | 983 |   |
| Foreign exchange (gain) loss                     |   |                | (26,811    | )      |         |   | (8,386     | )            |   |   | 4,198 |   |
| General and administrative (Note 4)              |   |                | 1,491,252  |   |         |   | 60,716     |         |   |   | 86,828 |   |
| Research and development (Note 2(n))             |   |                | 79,016     |   |         |   | 3,053      |         |   |   | 1,933 |   |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Total Operating Expenses                         |   |                | 1,559,192  |   |         |   | 56,125     |         |   |   | 93,942 |   |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Loss From Operations                             |   |                | (1,559,192 | )      |         |   | (56,125    | )            |   |   | (93,942 | ) |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Other Expenses                                   |   |                |       |   |         |   |       |         |   |   |   |   |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Accretion of discounts on convertible debentures |   |                | (349,539   | )      |         |   | (8,357     | )            |   |   | (731 | ) |
| Interest expense                                 |   |                | (61,107    | )      |         |   | (3,498     | )            |   |   | (2,648 | ) |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Total Other Expenses                             |   |                | (410,646   | )      |         |   | (11,855    | )            |   |   | (3,379 | ) |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Net Loss for the Period                          |   |                | (1,969,838 | )      |         |   | (67,980    | )            |   |   | (97,321 | ) |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Net Loss Per Share – Basic and Diluted     |   |                |       |   |         |   | –    |         |   |   | – |   |
|                                             |   |                |       |   |         |   |       |         |   |   |   |   |
| Weighted Average Shares Outstanding              |   |                |       |   |         |   | 45,670,000 |         |   |   | 44,713,000 |   |

----

|                                                                        |   | For the      |    |   | For the      |   |
|-----------------------------------------------------------------------------|--------|--------------|---------|--------|--------------|--------|
|                                                                        |   | Three months |    |   | Three months |   |
|                                                                        |   | Ended        |    |   | Ended        |   |
|                                                                        |   | March 31,    |    |   | March 31,    |   |
|                                                                        |   | 2010$        |    |   | 2009$        |   |
|                                                                        |   |         |    |   |         |   |   |   |
| Operating Activities                                                        |   |         |    |   |         |   |   |   |
|                                                                        |   |         |    |   |         |   |   |   |
| Net loss for the period                                                     |   |         | (67,980 | )      |         |   | (97,321 | ) |
|                                                                        |   |         |    |   |         |   |   |   |
| Adjustments to reconcile net loss to net cash used in operating activities: |   |         |    |   |         |   |   |   |
| Accretion of discounts on convertible debentures                            |   |         | 8,357   |   |         |   | 731 |   |
| Depreciation                                                                |   |         | 742     |   |         |   | 983 |   |
| Stock-based compensation                                                    |   |         | 2,320   |   |         |   | – |   |
| Foreign exchange translation (gain) loss                                    |   |         | (10,433 | )      |         |   | 4,115 |   |
|                                                                        |   |         |    |   |         |   |   |   |
| Changes in operating assets and liabilities:                                |   |         |    |   |         |   |   |   |
| Receivables                                                                 |   |         | (1,404  | )      |         |   | – |   |
| Investment tax credit receivable                                            |   |         | – |   |         |   | – |   |
| Prepaid expenses                                                            |   |         | – |   |         |   | 1,125 |   |
| Accounts payable and accrued liabilities                                    |   |         | (4,972  | )      |         |   | (7,706 | ) |
| Accrued convertible interest payable                                        |   |         | 3,498   |   |         |   | 2,648 |   |
|                                                                        |   |         |    |   |         |   |   |   |
| Net Cash Used In Operating Activities                                       |   |         | (69,872 | )      |         |   | (95,425 | ) |
|                                                                        |   |         |    |   |         |   |   |   |
| Decrease in Cash                                                            |   |         | (69,872 | )      |         |   | (95,425 | ) |
|                                                                        |   |         |    |   |         |   |   |   |
| Cash - Beginning of Period                                                  |   |         | 117,489 |   |         |   | 125,251 |   |
|                                                                        |   |         |    |   |         |   |   |   |
| Cash - End of Period                                                        |   |         | 47,617  |   |         |   | 29,826 |   |
|                                                                        |   |         |    |   |         |   |   |   |
| Supplemental Disclosures                                                    |   |         |    |   |         |   |   |   |
| Interest paid                                                               |   |         | – |   |         |   | – |   |
| Income taxes paid                                                           |   |         | – |   |         |   | – |   |

----

----

----

----

|               |   | Cost$  |   |   | AccumulatedAmortization$ |   |   | March 31, 2010Net CarryingValue$ |   |   | December 31, 2009Net CarryingValue$ |   |
|--------------------|--------|--------|--------|--------|--------------------------|--------|--------|----------------------------------|--------|--------|-------------------------------------|--------|
|               |   |   |   |   |                     |   |   |                             |   |   |                                |   |   |   |   |   |
| Equipment          |   |   | 13,617 |   |                     |   | 8,130  |                             |   |   | 5,487                               |   |   |   | 5,931 |   |
| Computer equipment |   |   | 3,283  |   |                     |   | 2,357  |                             |   |   | 926                                 |   |   |   | 1,001 |   |
| Office furniture   |   |   | 9,467  |   |                     |   | 5,248  |                             |   |   | 4,219                               |   |   |   | 4,442 |   |
|               |   |   |   |   |                     |   |   |                             |   |   |                                |   |   |   |   |   |
|               |   |   | 26,367 |   |                     |   | 15,735 |                             |   |   | 10,632                              |   |   |   | 11,374 |   |

----

| a)   | On July 30, 2008, the Company entered into a convertible debenture agreement with a company controlled by the President of the Company. The Company received US$36,376 ($36,960) which bears interest at 10% per annum and is due five years from the advancement date. No interest shall be payable for the first year from the advancement date but shall accrue from theadvancement date and all accrued interest shall be payable annually, on the subsequent anniversaries of the advancement date. Proceeds of the loan are to be used to acquire certain patents and intellectual property rights and the loan amount is secured against such intellectual property. The loan and any unpaid interest at the conversion date are convertible into shares of common stock at a conversion price of US$0.17 per share. The Company recognized the intrinsic value of the embedded beneficial conversionfeature of US$6,419 ($6,523) as additional paid-in capital and reduced the carrying value of the convertible debenture to US$29,957 ($30,437). The carrying value will be accreted over the term of the convertible debenture up to its face value of US$36,376. As at March 31, 2010, the carrying values of the convertible debenture and accrued convertible interest payable thereon were $32,201 and $6,165, respectively, after translation into Canadian dollars. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b)   | On October 16, 2008, the Company entered into a convertible debenture agreement with the President of the Company. The Company received US$50,000 ($59,110) which bears interest at 10% per annum and is due five years from the advancement date. No interest shall be payable for the first year from the advancement date but shall accrue from the advancement date andall accrued interest shall be payable annually, on the subsequent anniversaries of the advancement date. Proceeds of the loan are to be used to repay an outstanding loan and to further business development and research and development activities. The loan and any unpaid interest at the conversion date are convertible into shares of common stock at a conversion price of US$0.07 per share. The Company recognized the intrinsic value of the embedded beneficial conversion feature of US$14,286 ($16,889) as additionalpaid-in capital and reduced the carrying value of the convertible debenture to US$35,714 ($42,221). The carrying value will be accreted over the term of the convertible debenture up to its face value of US$50,000. As at March 31, 2010, the carrying values of the convertible debenture and accrued convertible interest thereon were $39,261 and $7,389, respectively, after translation into Canadian dollars. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c)   | On April 9, 2009, the Company entered into a convertible loan agreement with a company controlled by directors of the Company. The Company received US$202,920 ($250,000) which bears interest at 10% per annum and is due five years from the advancement date. No interest shall accrue for the first year from the advancement date but shall begin to accrue on the secondanniversary of the advancement date and all accrued interest shall be payable annually, on the subsequent anniversaries of the advancement date. Proceeds from the loan are to be used to further advance current business development and marketing initiatives, and to complete testing. The loan amount is secured against intellectual property rights owned by the Company. The loan and any unpaid interest at the conversion date are convertible into shares of common stock at a conversion price of US$0.06 per share. TheCompany recognized the intrinsic value of the embedded beneficial conversion feature of US$101,460 ($125,000) as additional paid-in capital and reduced the carrying value of the convertible debenture to US$101,460 ($125,000). The carrying value will be accreted over the term of the convertible debenture up to its face value of US$202,920. As at March 31, 2010, the carrying value of the convertible debenture was $128,456, after translation into Canadian dollars. |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| d)   | On December 31, 2009, the Company entered into a convertible loan agreement with a company controlled by the President of the Company. The Company received US$50,000 ($52,550) which bears interest at 10% per annum and is due five years from the advancement date. Interest shall accrue from the advancement date and shall be payable on the fifth anniversary of theadvancement date. Proceeds of the loan are to be used to continue with current business development activities. The loan and any unpaid interest at the conversion date are convertible into shares of common stock at a conversion price of US$0.05 per share. As at March 31, 2010, the carrying values of the convertible debenture and accrued convertible interest thereon were $50,790 and $1,252, respectively, after translation into Canadian dollars. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| a)   | On December 9, 2008, the Company received $25,000 from a company controlled by the President of the Company. The amount owing is unsecured, non-interest bearing, and has no specified repayment terms. As at March 31, 2010, the Company owed this company $1,906 (December 31, 2009 - $1,906) for payment of expenses on behalf of the Company. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b)   | On September 5, 2008, the Company entered into a loan agreement with a company controlled by the President of the Company. The Company received US$25,000 ($26,388) which is non-interest bearing and is due five years from the advancement date. As at March 31, 2010, the loan payable was $25,395 (December 31, 2009 - $26,275) after translation into Canadian dollars. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| a)   | On February 8, 2010, the Company issued 75,000 shares of common stock at a value of $2,627 as compensation for investor relations and marketing services per the terms of an agreement dated July 1, 2009. This amount was included in common stock to be issued at December 31, 2009. Refer to Note 9(c). |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b)   | On January 8, 2010, the Company was to issue 75,000 shares of common stock at a value of $2,320 as compensation for investor relations and marketing services per the agreement described in Note 9(c).  This amount is included in common stock to be issued at March 31, 2010. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c)   | On December 16, 2009, the Company issued 125,000 shares of common stock to a former employee according to the employment agreement referred to in Note 9(a) for services performed for the years ended July 28, 2008 and 2009. As at December 31, 2009, the 375,000 shares purchase warrants that were to have been issued under the agreement were not issued, however, 375,000shares were issued in error.  At December 31, 2009, the par value of these shares had been recorded as additional paid-in capital and 375,000 of the share purchase warrants have been presented as issued. On February 1, 2010, the Company cancelled the additional 375,000 shares. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                              |   | Number of Warrants |      |   | Weighted Average ExercisePrice |   |
|-----------------------------------|--------|--------------------|-----------|--------|--------------------------------|--------|
|                              |   |               |      |   |                           |   |
| Balance – December 31, 2009 |   |               | 4,624,277 |   |                           | $      | US0.15 |   |
|                              |   |               |      |   |                           |   |   |   |
| Expired                           |   |               | (970,585  | )      |                           | $      | US0.30 |   |
|                              |   |               |      |   |                           |   |   |   |
| Balance – March 31, 2010    |   |               | 3,653,692 |   |                           | $      | US0.11 |   |

| Number of Warrants | Exercise Price | Expiry Date      |
|--------------------|----------------|------------------|
|               |           |             |
| 3,278,692          | US$0.11        | February 5, 2011 |
| 187,500            | US$0.23        | July 28, 2010    |
| 187,500            | US$0.07        | July 28, 2011    |
| 3,653,692          |           |             |

----

| a)   | On July 28, 2006, the Company’s board of directors resolved to issue certain share-based payments to an employee of the Company over a three year period. Under the arrangement, the employee was to be issued 62,500 shares of common stock and 187,500 share purchase warrants, each on July 28, 2006, 2007, 2008, and 2009. The Company issued 62,500 shares on eachof March 15, 2007 and August 19, 2008, and issued 125,000 shares on December 16, 2009. On September 12, 2008, the employee resigned and became a consultant to the Company (refer to Note 9(b)). It was mutually agreed that the former employee was entitled to the remaining shares and warrants to be issued under the arrangement. For the year ended December 31, 2009, stock-based compensation of $7,823 (2008 - $33,918) was recorded for the 187,500 warrants earned on July 28, 2009 (2008 – July 28, 2008). |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b)   | On September 15, 2008, the Company entered into a consulting agreement with the former employee in Note 9(a), for administrative services. Pursuant to the agreement, the Company agreed to pay the former employee $6,800 per month. This agreement may be terminated upon three months prior written notice. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c)   | On July 1, 2009, the Company entered into an investor relations agreement.  Pursuant to the agreement, the Company agreed to pay a fee of $1,000 per month for a period of six months beginning on August 1, 2009, and ending January 1, 2010. The Company must also issue 75,000 shares within 7 days of signing the agreement.  Any payments over 45 dayswill be subject to a penalty fee of 10% per week.  On February 8, 2010, the Company issued 75,000 shares of common stock, which was included in common stock to be issued at December 31, 2009.  On January 1, 2010, the agreement was extended for twelve months and the Company will issue an additional 75,000 shares.  As at March 31, 2010, the shares have not been issued and have been included in common stock to be issued. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| d)   | On October 15, 2009, the Company entered into a license agreement with a licensee to grant a non-exclusive license to use, market and sell the Company’s intellectual property for a period of two years.  License and royalty fees are to be determined prior to the first sale.   At the end of the two year period, the agreement can be renewedfor a successive two year period by mutual agreement. |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

| Area          |   | Filing Number |
|---------------|--------|---------------|
| United States |   | 6,622,482     |
|          |   | 7,108,590     |
| Canada        |   | 2,448,742     |
|          |   | 2,448,648     |
| Europe        |   | 02742591.7    |

----

|                                |   |   | $       |   |
|-------------------------------------|--------|--------|---------|--------|
| Sales and marketing expenses        |   |   | 110,000 |   |
| Research and development expenses   |   |   | 80,000  |   |
| General and administrative expenses |   |   | 80,000  |   |
| Total                               |   |   | 270,000 |   |

----

----

----

|                              |   | Three Months EndedMarch 31,2010 |    |   | Three Months EndedMarch 31,2009 |   |    | Change BetweenThree Month PeriodEndedMarch 31, 2010andMarch 31, 2009 |   |
|-----------------------------------|--------|---------------------------------|---------|--------|---------------------------------|--------|---------|----------------------------------------------------------------------|--------|
| Revenue                           |   | $                               | Nil     |   |                            | $      | Nil     |                                                                 |   | $ | Nil |   |
| Depreciation                      |   |                            | 742     |   |                            |   | 983     |                                                                 |   |   | (241 | ) |
| Foreign exchange loss (gain) loss |   |                            | (8,386  | )      |                            |   | 4,198   |                                                                 |   |   | (12,584 | ) |
| General and administrative        |   |                            | 60,716  |   |                            |   | 86,828  |                                                                 |   |   | (26,112 | ) |
| Research and development          |   |                            | 3,053   |   |                            |   | 1,933   |                                                                 |   |   | 1,120 |   |
| Net (Loss)                        |   | $                               | (56,125 | )      |                            | $      | (93,942 | )                                                                    |   | $ | 37,817 |   |

----

|                      |   | At March 31, 2010 |    |   | At December 31, 2009 |   |
|---------------------------|--------|-------------------|---------|--------|----------------------|--------|
| Current assets            |   | $                 | 72,307  |   |                 |   | 140,775 |   |
| Current liabilities       |   |              | 86,550  |   |                 |   | 88,977 |   |
| Working capital (deficit) |   | $                 | (14,243 | )      |                 |   | 51,798 |   |

|                                          |   | At March 31, 2010 |    |   | At March 31, 2009 |   |
|-----------------------------------------------|--------|-------------------|---------|--------|-------------------|--------|
| Net cash used in operating activities         |   | $                 | (69,872 | )      |              |   | (95,425 | ) |
| Net cash used in investing activities         |   | Nil               |    |   | Nil               |   |
| Net cash provided by financing activities     |   | Nil               |    |   | Nil               |   |
| Effect of exchange rate changes on cash       |   | Nil               |    |   | Nil               |   |
| Net increase (decrease) in cash during period |   | $                 | (69,872 | )      |              |   | (95,425 | ) |

----

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Item 4. Controls and Procedures.

----

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Item 1A. Risk Factors

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Item 3. Defaults Upon Senior Securities

Item 4. [Removed and Reserved]

Item 5. Other Information

----

Item 6. Exhibits

| Exhibit Number | Description                                                                                                                                                                   |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (3)            | Articles of Incorporation and Bylaws                                                                                                                                          |
| 3.1            | Articles of Incorporation (incorporated by reference from our Registration Statement on Form SB-2 filed on May 4, 2005).                                                      |
| 3.2            | By-laws (incorporated by reference from our Registration Statement on Form SB-2 filed on May 4, 2005).                                                                        |
| (10)           | Material Contracts                                                                                                                                                            |
| 10.1           | Contribution Agreement with National Research Council of Canada Industrial Research Program (incorporated by reference from our Current Report on Form 8-K February 4, 2009). |
| (14)           | Code of Ethics                                                                                                                                                                |
| 14.1           | Code of Ethics (incorporated by reference from our Annual Report on Form 10-KSB filed on April 15, 2008).                                                                     |
| (31)           | Section 302 Certifications                                                                                                                                                    |
| 31.1*          | Section 302 Certification of Principal Executive Officer.                                                                                                                     |
| 31.2*          | Section 302 Certification of Principal Financial Officer and Principal Accounting Officer.                                                                                    |
| (32)           | Section 906 Certification                                                                                                                                                     |
| 32.1*          | Section 906 Certification of Principal Executive Officer.                                                                                                                     |
| 32.2*          | Section 906 Certification of Principal Financial Officer and Principal Accounting Officer.                                                                                    |

----

|                           | ENVIRONMENTAL CONTROL CORP.                                    |
|--------------------------------|----------------------------------------------------------------|
|                           | (Registrant)                                                   |
|                           |                                                           |
| Dated:  May 17, 2010 | /s/ Albert Hickman                                             |
|                           | Albert Hickman                                                 |
|                           | President and Chief Executive Officer                          |
|                           | (Principal Executive Officer)                                  |
|                           |                                                           |
| Dated:  May 17, 2010 | /s/ Gary Bishop                                                |
|                           | Gary Bishop                                                    |
|                           | Chief Financial Officer                                        |
|                           | (Principal Financial Officer and Principal Accounting Officer) |